Problem: A 32-year-old cisgender woman presents to her primary care medical provider's office with abnormal vaginal discharge. She is diagnosed with cervical chlamydia and treated with a course of doxycycline. She is not pregnant. Her two sex partners, both of whom are cisgender men, are notified and both received evaluation and treatment for chlamydial infection. She has been asymptomatic following the treatment course with doxycycline. Which one of the following should be recommended regarding routine follow-up chlamydial testing for this woman? Perform a test-of-cure with nucleic acid amplification test (NAAT) 10 days after treatment completion Perform a test-of-cure with nucleic acid amplification test (NAAT) 3 weeks after treatment completion Retest with a nucleic acid amplification test (NAAT) 3 months after completion of therapy Routine follow-up testing is not recommended